Finivi Inc. Invests $839,000 in SPDR S&P Biotech ETF $XBI

Finivi Inc. bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to the company in its most recent filing with the SEC. The firm bought 5,302 shares of the exchange traded fund’s stock, valued at approximately $839,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Axiom Investment Management LLC acquired a new position in SPDR S&P Biotech ETF in the first quarter valued at about $26,000. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $30,000. Finally, SHP Wealth Management bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $31,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $157.37 on Monday. The company has a market capitalization of $10.28 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a one year low of $84.81 and a one year high of $165.71. The business’s 50 day simple moving average is $148.00 and its 200-day simple moving average is $135.41.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.